Drug Profile
Carbidopa/levodopa - Contera Pharma
Alternative Names: CP-012; JM 012; SOL 707Latest Information Update: 19 Jan 2024
Price :
$50
*
At a glance
- Originator Contera Pharma; Ernst-Moritz-Arndt-University of Greifswald; Solural Pharma
- Developer Contera Pharma
- Class Antiasthmatics; Antiparkinsonians; Aromatic amino acids; Catecholamines; Hydrazines; Small molecules
- Mechanism of Action Decarboxylase inhibitors; Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Paralysis